INTUITIVE SURGICAL INC ISRG

Latest FY: 2025 Healthcare Medical Instruments & Supplies
Market Price $394.48
Market Cap $142.15B
P/E Ratio 50.12
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑20.5% YoY
$10.06B
3-Yr CAGR: 17.4%
Net Income ↑23.0% YoY
$2.86B
Net Margin: 28.4%
Free Cash Flow ↑91.0% YoY
$2.49B
FCF Yield: 1.75%
EPS (Diluted) ↑22.6% YoY
$7.87
Basic: $8.00
Return on Equity Efficiency
16.0%
ROA: 598.4%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (ISRG)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $2,704.4M $1,890.1M $735.9M $2.08 $1,042.9M $989.0M
FY 2017 $3,128.9M +15.7% $2,194.1M $660.0M -10.3% $1.89 -9.2% $1,143.9M $953.2M -3.6%
FY 2018 $3,724.2M +19.0% $2,604.1M $1,127.9M +70.9% $3.16 +67.4% $1,169.6M $982.2M +3.0%
FY 2019 $4,478.5M +20.3% $3,110.2M $1,379.3M +22.3% $3.85 +21.6% $1,598.2M $1,172.6M +19.4%
FY 2020 $4,358.4M -2.7% $2,861.2M $1,060.6M -23.1% $2.94 -23.6% $1,484.8M $1,143.3M -2.5%
FY 2021 $5,710.1M +31.0% $3,958.5M $1,704.6M +60.7% $4.66 +58.5% $2,089.4M $1,735.9M +51.8%
FY 2022 $6,222.2M +9.0% $4,196.0M $1,322.3M -22.4% $3.65 -21.7% $1,490.8M $958.4M -44.8%
FY 2023 $7,124.1M +14.5% $4,729.5M $1,798.0M +36.0% $5.03 +37.8% $1,813.8M $749.6M -21.8%
FY 2024 $8,352.1M +17.2% $5,634.2M $2,322.6M +29.2% $6.42 +27.6% $2,415.0M $1,303.8M +73.9%
FY 2025 $10,064.7M +20.5% $6,642.3M $2,856.0M +23.0% $7.87 +22.6% $3,030.5M $2,490.7M +91.0%
$

Valuation

Market Price $394.48
Market Cap $142.15B
Enterprise Value N/A
P/E Ratio 50.12
P/B Ratio 7.84
FCF Yield 1.75%
Dividend Yield N/A
Shares Outstanding 354,162,800
%

Profitability & Margins

Gross Margin 66.00%
Operating Margin 29.27%
Net Margin 28.38%
Return on Equity (ROE) 16.02%
Return on Assets (ROA) 598.37%
Asset Turnover 21.09x
Revenue 3-Yr CAGR 17.39%
🛡️

Financial Health & Liquidity

Current Ratio 0.24
Cash Ratio 1.68
Debt / Equity N/A
Debt / Assets N/A
Cash & Equivalents $3.37B
Total Debt N/A
Book Value / Share $50.33
💧

Cash Flow Efficiency

Operating Cash Flow $3.03B
Capital Expenditures (CapEx) $539.80M
Free Cash Flow $2.49B
OCF / Revenue 30.11%
FCF / Revenue 24.75%
FCF 3-Yr CAGR 37.49%
🏷️

Per Share Metrics

EPS (Diluted) $7.87
EPS (Basic) $8.00
Dividends / Share N/A
Book Value / Share $50.33
EPS YoY Growth 22.59%
🏛️

Balance Sheet (FY 2025)

Total Assets $477.30M
Total Liabilities $2.01B
Stockholders' Equity $17.82B
Current Assets $477.30M
Current Liabilities $2.01B